Interaction of Wratizolin with serum albumins and its antiproteolytic activity.
D000818:Animals; D002417:Cattle; D002850:Chromatography, Gel; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D003619:Dansyl Compounds / Q000378:metabolism; D006736:Horses; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D010047:Ovalbumin / Q000378:metabolism; D011480:Protease Inhibitors; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism*; D012710:Serum Albumin, Bovine / Q000378:metabolism; D013844:Thiazoles / Q000494:pharmacology*; D014361:Trypsin Inhibitors / Q000378:metabolism; D014364:Tryptophan / Q000378:metabolism; D014527:Uric Acid / Q000378:metabolism
D003619:Dansyl Compounds; D011480:Protease Inhibitors; D012709:Serum Albumin; D013844:Thiazoles; D014361:Trypsin Inhibitors; D014527:Uric Acid; D012710:Serum Albumin, Bovine; C027999:5-(benzoylamino)-N-(4-chlorophenyl)-3-methyl-4-isothiazolecarboxamide; D014364:Tryptophan; D010047:Ovalbumin; D002918:Chymotrypsin; D007213:Indomethacin